MTND2P23

Across TCGA pan-cancer cohorts, MTND2P23 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of MTND2P23’s most consistent transcriptional readouts.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where MTND2P23 RNA is repressed in tumor relative to normal tissue. In most cancer types MTND2P23 is over-expressed in tumor, although a few such as LUSC and KIRC show the opposite, repressed pattern.

LUSC and KIRC are the cancer types where MTND2P23 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MTND2P23 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUSC	Female	All	−0.042	.014	2	view →
KIRC	Male	II,III,IV	−0.012	.023	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

MTND2P23–LUSC

Open the LUSC breakdown →